Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(0)
# 4506
Out of 5,329 analysts
415
Total ratings
24.79%
Success rate
-15.80%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
QURE uniQure | Reiterates: Buy | 70 70 | 14.98 | 367.29% | 14 | Apr 21, 2025 | |
VYGR Voyager Therapeutics | Reiterates: Buy | 30 30 | 3.58 | 737.99% | 10 | Apr 8, 2025 | |
HRMY Harmony Biosciences ... | Reiterates: Buy | 70 70 | 29.9 | 134.11% | 6 | Apr 8, 2025 | |
ANRO Alto Neuroscience | Initiates Coverage On: Buy | 10 | 2.44 | 309.84% | 1 | Apr 7, 2025 | |
SGMO Sangamo Therapeutics | Reiterates: Buy | 10 10 | 0.74 | 1251.35% | 25 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 80 80 | 19.91 | 301.81% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 5.2 | 130.77% | 17 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 500 500 | 255.12 | 95.99% | 26 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 10 | 1.32 | 657.58% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 60 60 | 5.74 | 945.3% | 17 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 0.61 | 1539.34% | 17 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 1.47 | 580.27% | 18 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 1.04 | 861.54% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 100 100 | 30.15 | 231.67% | 20 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 5 | 0.55 | 809.09% | 17 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 55 55 | 6.62 | 730.82% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 75 75 | 4.01 | 1770.32% | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 45 45 | 4.09 | 1000.24% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 110 110 | 6.11 | 1700.33% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 85 85 | 30.21 | 181.36% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 190 150 | 6.56 | 2186.59% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 80 80 | 14.06 | 468.99% | 22 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 40 40 | 10.76 | 271.75% | 14 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 80 60 | n/a | n/a | 14 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 15 7 | n/a | n/a | 8 | Nov 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 360 | n/a | n/a | 5 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 | n/a | n/a | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 20 | n/a | n/a | 1 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 3 | n/a | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | n/a | n/a | 1 | Oct 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 170 68 | 14.44 | 370.91% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 7 | n/a | n/a | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 120 100 | n/a | n/a | 3 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 230 20 | 0.33 | 5960.61% | 2 | Dec 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 500 625 | n/a | n/a | 2 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 10 | n/a | n/a | 3 | Oct 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 260 340 | 278.48 | 22.09% | 1 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | n/a | n/a | 1 | Jul 26, 2021 |